| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $80.0M | +104.9% |
| Cost of Revenue | $37.2M | +138.5% |
| Gross Profit | $42.7M | +82.6% |
| R&D Expense | $7.8M | +138.6% |
| SG&A Expense | $35.8M | +57.4% |
| Operating Income | -$844K | +67.5% |
| Interest Expense | $4.8M | +138.5% |
| Pre-tax Income | -$4.6M | -19.7% |
| Income Tax | $43K | +186.7% |
| Net Income | -$4.6M | -20.4% |
| EPS (Basic) | -$0.17 | -13.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.9M | +73.7% |
| Accounts Receivable | $11.8M | +119.3% |
| Inventory | $15.4M | +1.2% |
| Current Assets | $60.6M | +47.7% |
| Total Assets | $92.1M | +21.0% |
| Current Liabilities | $38.5M | +93.0% |
| Long-term Debt | $21.8M | -27.0% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.5M | +986.1% |
| Capital Expenditures | $333K | +1180.8% |
| Investing Cash Flow | -$333K | +99.2% |
| Financing Cash Flow | $815K | -97.5% |
| Free Cash Flow | $10.2M | +980.7% |
| $66.0M |
| +27.6% |
| Stockholders' Equity | $26.2M | +7.1% |